Genentech Xolair Injection Recalled for Failed Stability Specifications
Genentech is recalling two lots of Xolair (omalizumab) injection nationwide due to out-of-specification Polysorbate 20 content detected at the 12-month stability testing timepoint. The affected lots are 3352758 and 3352759, both with August 2021 expiration dates.
- Product
- XOLAIR — XOLAIR (OMALIZUMAB)
- Category
- Drug
- Distribution
- Distributed nationwide